Clinical Trials Browser

Enrolling by invitation × OTHER × Genitourinary × Clear all

NCT07205783 2026-04-07

Open Radical Prostatectomy Versus Curative Radiotherapy for Treatment of Organ Confined Prostate Cancer (Retrospective Comparative Study)

Phase NA Enrolling by invitation

Prostatic Neoplasms

NCT07488572 2026-03-23

Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study

Phase 2 Enrolling by invitation

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT05700461 2026-03-20

Drug Screening Using Novel IMD in Renal Cell Carcinoma

Phase 1 Enrolling by invitation

Carcinoma, Renal Cell, Kidney Neoplasms

NCT05160480 2026-03-10

A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG

Enrolling by invitation

BreastEndocrineGenitourinaryNET

Breast Neoplasms, Prostatic Neoplasms, Neuroendocrine Tumors

NCT07454941 2026-03-06

Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Omics

Enrolling by invitation

Carcinoma, Transitional Cell, Disease

NCT06238661 2026-03-05

ProScreenMRI

Phase NA Enrolling by invitation

Prostatic Neoplasms

NCT05195515 2026-03-03

CONQUER

Enrolling by invitation

Urinary Bladder Neoplasms

NCT07405099 2026-02-27

Operative Risk After Pancreatic Surgery in Patients With End Stage Renal Disease

Enrolling by invitation

GastrointestinalGenitourinary

Kidney Failure, Chronic, Pancreatic Neoplasms

NCT07439913 2026-02-27

Predictive Factors for 10-year Biochemical Recurrence and Urinary Continence Following Robot-assisted Radical Prostatectomy for Prostate Cancer

Enrolling by invitation

Adenocarcinoma, Prostatic Neoplasms

NCT04254133 2026-01-30

GIFTS

Enrolling by invitation

Prostatic Neoplasms

NCT06243510 2026-01-28

CARE

Phase NA Enrolling by invitation

Urinary Bladder Neoplasms

NCT05443321 2026-01-23

Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes

Phase NA Enrolling by invitation

GastrointestinalGenitourinary

Arrhythmias, Cardiac, Asthma, Cardiovascular Diseases, Gastrointestinal Diseases, Heart Failure, Hematologic Diseases, Infections, Kidney Diseases, Nervous System Diseases, Rheumatic Diseases, Shock, Urologic Diseases, Critical Illness, Renal Insufficiency

NCT06472817 2026-01-21

Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men

Enrolling by invitation

Prostatic Neoplasms

NCT05570994 2026-01-08

177Lu-HTK03170 in mCRPC With PSMA Positive Disease

Phase 1/2 Enrolling by invitation

Metastatic Castration-resistant Prostate Cancer

NCT07307157 2025-12-29

COSMO

Enrolling by invitation

CNSGenitourinaryThoracic

Brain Neoplasms, Disease, Kidney Neoplasms, Lung Neoplasms

NCT06604130 2025-11-28

exo-PRECISE

Phase NA Enrolling by invitation

Disease, Prostatic Neoplasms

NCT06935097 2025-11-10

Mediterranean Diet Intervention Among Men at LBJ Hospital With Prostate Cancer

Phase NA Enrolling by invitation

Prostatic Neoplasms

NCT03544983 2025-10-29

Genetic Education in BRCA Families

Phase NA Enrolling by invitation

BreastGenitourinaryGynecologic

Breast Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms

NCT07148765 2025-09-26

Use of Wearables Following Cystectomy- Part II

Phase NA Enrolling by invitation

Urinary Bladder Neoplasms, Urinary Bladder, Neurogenic

NCT03648359 2025-09-12

Multiparametric MRI in Men With Prostate Cancer Enrolled in Active Surveillance

Phase NA Enrolling by invitation

Prostatic Neoplasms

NCT05739071 2025-09-11

JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer

Phase NA Enrolling by invitation

Urinary Bladder Neoplasms, Lower Urinary Tract Symptoms

NCT06424275 2025-08-15

PRAISE-U

Enrolling by invitation

20,000 enrolled

Prostatic Neoplasms

NCT07101900 2025-08-08

68Ga-NYM096 PET/ CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses

Phase 2 Enrolling by invitation

Carcinoma, Renal Cell

NCT07112209 2025-08-08

Clinical Study of Rezvilutamide Combined With Docetaxel Chemotherapy in the Treatment of Abiraterone-Resistant Prostate Cancer

Phase NA Enrolling by invitation

Pathological and Imaging Examinations Confirmed Metastatic Prostate Cancer

NCT07091565 2025-08-03

SPARC

Enrolling by invitation

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT07082049 2025-07-24

AI-CAP

Phase NA Enrolling by invitation

Anxiety Disorders, Prostatic Neoplasms

NCT07075666 2025-07-20

Early Detection of Prostate Cancer of Syrian Men

Enrolling by invitation

the Detection of Prostate Cancer in Men

NCT07023848 2025-06-17

PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors

Phase EARLY_PHASE1 Enrolling by invitation

BreastGastrointestinalGenitourinary

Breast Neoplasms, Carcinoma, Transitional Cell, Stomach Neoplasms

NCT07023861 2025-06-17

The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies

Phase EARLY_PHASE1 Enrolling by invitation

BreastGastrointestinalGenitourinary

Breast Neoplasms, Carcinoma, Transitional Cell, Stomach Neoplasms

NCT05844761 2025-05-21

REMIND

Phase NA Enrolling by invitation

GenitourinaryThoracic

Lung Neoplasms, Prostatic Neoplasms

NCT03503643 2025-05-13

Hemi-Gland Cryoablation for Prostate Cancer at UCLA

Enrolling by invitation

Prostatic Diseases, Prostatic Neoplasms

NCT05753046 2025-04-27

TAPBlock

Phase 4 Enrolling by invitation

Prostatic Neoplasms

NCT06944314 2025-04-27

Physicians' Perception About Patient Pain in Flexible Cystoscopy With Local Anesthesia

Phase NA Enrolling by invitation

Anxiety Disorders, Urinary Bladder Neoplasms, Hematuria, Pain

NCT03423303 2025-04-17

ProScreen

Phase NA Enrolling by invitation

17,400 enrolled

Prostatic Neoplasms

NCT06223022 2025-04-02

Nurse-led Proactive Telephone Follow-up With Patients After Completion of Primary Cancer Treatment

Phase NA Enrolling by invitation

BreastGastrointestinalGenitourinary

Breast Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT06470685 2025-03-27

PPPC

Enrolling by invitation

Prostatic Neoplasms, Genetic Predisposition to Disease

NCT06505356 2025-03-13

Characterization of Microbiological and Genetic Features in Prostate Cancer and Their Association with Disease Stage

Phase NA Enrolling by invitation

Prostatic Neoplasms, Prostatitis

NCT06080113 2025-03-12

CAPFIRE

Phase NA Enrolling by invitation

Prostatic Neoplasms

NCT06865547 2025-03-10

ProA

Enrolling by invitation

Adenocarcinoma, Prostatic Neoplasms

NCT06864572 2025-03-07

[68Ga]Ga-P17-079 in the Diagnosis and Treatment of Metastatic Prostate Cancer

Phase EARLY_PHASE1 Enrolling by invitation

Prostatic Neoplasms

NCT06723665 2025-01-24

The Exploration of 18F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients

Phase NA Enrolling by invitation

Prostatic Neoplasms

NCT06540794 2024-12-10

Evaluating Respiratory Effects of Driving Pressure Guided Mechanical Ventilation Using Electrical Impedance Tomography in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy

Phase NA Enrolling by invitation

Prostatic Neoplasms

NCT06565585 2024-08-23

Prediction of Local Recurrence and Its Impact on Long-term Outcomes After Low-risk Glans-sparing Surgery for Penile Squamous Cell Carcinoma

Enrolling by invitation

Penile Neoplasms, Recurrence

NCT06541821 2024-08-07

Physical Activity, Kinesiophobia, and Stoma Compliance in Urostomy Patients

Enrolling by invitation

Urinary Bladder Neoplasms

NCT02526797 2024-02-28

Multiparametric MRI in Men With Prostate Cancer Undergoing Active Surveillance

Enrolling by invitation

Prostatic Neoplasms

NCT03459820 2023-11-27

Prostate Cancer Patient Management With 18F-DCFPyL PET/CT

Phase 2/3 Enrolling by invitation

Prostatic Neoplasms

NCT06145139 2023-11-22

KIDNEY-PAGER

Enrolling by invitation

Kidney Neoplasms